IP Library Assignment 032277/0353
Patent Assignment
Reel/Frame 032277/0353

Security Agreement

Recorded: 2014-02-19 Pages: 10
Assignors
IMMUNE PHARMACEUTICALS INC.
Executed: 2014-02-19
MAXIM PHARMACEUTICALS, INC.
Executed: 2014-02-19
CYTOVIA, INC.
Executed: 2014-02-19
Assignee
MIDCAP FUNDING III, LLC
7255 WOODMONT AVENUE, SUITE 200, BETHESDA, MARYLAND, 20814
Covered Properties (10)
4-Arylamino-Quinazolines and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent: 7,618,975 →
Application: 10/885,903 →
Publication: US 2005/0137213
Compounds and Therapeutical Use Thereof
Application: 11/620,498 →
Publication: US 2007/0208044
Methods of Preparing Dosage Compositions Containing Substituted (4-Phenyl)-Methyl-(Quinazolin-4-Yl)-Amine Compounds
Application: 11/692,655 →
Publication: US 2007/0249632
Method of Treating Brain Cancer
Patent: 8,258,145 →
Application: 11/773,285 →
Publication: US 2008/0051398
Pharmaceutical Compounds as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent: 7,842,805 →
Application: 11/773,293 →
Publication: US 2008/0020985
4-Arylamin-Or-4-Heteroarylamino-Quinazolines and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent: 7,989,462 →
Application: 11/773,303 →
Publication: US 2008/0004297
Compounds and Therapeutical Use Thereof
Patent: 8,309,562 →
Application: 12/500,863 →
Publication: US 2010/0069383
Pharmaceutical Compounds as Cytotoxic Agents and Uses Thereof
Application: 13/004,311 →
Publication: US 2011/0200619
Methods of Treating Cancer and Related Diseases
Application: 13/004,656 →
Publication: US 2011/0224240
Compounds and Therapeutical Uses Thereof
Application: 13/644,419 →
Publication: US 2013/0029942
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 20, 2004
From: PLEIMAN, CHRIS; BAICHWAL, VIJAY; MANFREDI, JOHN; BHOITE, LEENA
To: MYRIAD GENETICS, INC.
Reel/Frame 015151/0933 →
Assignment of Assignor's Interest Sep 20, 2004
From: CAI, SUI XIONG; SIRISOMA, NILANTHA SUDATH; PERVIN, AZRA; DREWE, JOHN A.
To: CYTOVIA, INC.
Reel/Frame 015152/0032 →
Assignment of Assignor's Interest Sep 13, 2007
From: ANDERSON, MARK B.; WILLARDSEN, ADAM; SUZUKI, KAZUYUKI
To: MYRIAD GENETICS, INC.
Reel/Frame 019823/0470 →
Assignment of Assignor's Interest Sep 18, 2007
From: CAI, SUI-XIONG; SIRISOMA, NILANTHA SUDATH; ZHANG, HONG
To: CYTOVIA, INC.
Reel/Frame 019844/0416 →
Assignment of Assignor's Interest Oct 4, 2007
From: ANDERSON, MARK B.; WILLARDSEN, ADAM
To: MYRIAD GENETICS, INC.
Reel/Frame 019922/0573 →
Assignment of Assignor's Interest Oct 4, 2007
From: CAI, SUI-XIONG; SIRISOMA, NILANTHA SUDATH
To: CYTOVIA, INC.
Reel/Frame 019922/0630 →
Assignment of Assignor's Interest Oct 4, 2007
From: CAI, SUI-XIONG; JIANG, SONGCHUN
To: CYTOVIA, INC.
Reel/Frame 019921/0773 →
Assignment of Assignor's Interest Oct 4, 2007
From: ANDERSON, MARK B.; WILLARDSEN, ADAM; HALTER, ROBERT J.; SLADE, RACHEL
To: MYRIAD GENETICS, INC.
Reel/Frame 019919/0932 →
Assignment of Assignor's Interest Aug 6, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023061/0882 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0158 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0132 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0172 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023137/0588 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023137/0716 →
Assignment of Assignor's Interest Nov 6, 2009
From: ANDERSON, MARK B.; WILLARDSEN, J. ADAM; WEINER, WARREN S.; YUNGAI, ASHANTAI
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023484/0145 →
Change of Name Aug 17, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024849/0119 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0711 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0508 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0213 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0911 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0657 →
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024852/0481 →
Assignment of Assignor's Interest May 2, 2011
From: ANDERSON, MARK B.; KIM, IN CHUL
To: MYREXIS, INC.
Reel/Frame 026212/0135 →
Assignment of Assignor's Interest May 26, 2011
From: PLEIMAN, CHRISTOPHER M.; MATHER, GARY G.
To: MYREXIS, INC.
Reel/Frame 026348/0206 →
Release of Security Interest Aug 5, 2015
From: MIDCAP FINANCIAL TRUST
To: IMMUNE PHARMACEUTICALS, INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
Reel/Frame 036255/0778 →